XML 128 R111.htm IDEA: XBRL DOCUMENT v3.3.1.900
Condensed Consolidating Financial Statements (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Condensed, Consolidating Statement of Operations                      
Net sales $ 1,115.8 $ 927.4 $ 1,311.5 $ 953.6 $ 1,216.5 $ 921.4 $ 1,472.7 $ 1,132.6 $ 4,308.3 $ 4,743.2 $ 5,474.7
Cost of sales                 2,761.2 2,964.7 2,954.5
Gross margin 280.4 165.0 685.9 415.8 444.3 301.1 590.3 442.8 1,547.1 1,778.5 2,520.2
Selling, general and administrative expenses                 169.8 151.9 166.0
Transaction costs                 56.9 0.0 0.0
Other operating—net                 92.3 53.3 (15.8)
Total other operating costs and expenses                 319.0 205.2 150.2
Gain on sale of phosphate business                 0.0 750.1 0.0
Equity in earnings of operating affiliates                 (35.0) 43.1 41.7
Operating earnings                 1,193.1 2,366.5 2,411.7
Interest expense                 133.2 178.2 152.2
Interest income                 (1.6) (0.9) (4.7)
Net earnings of wholly-owned subsidiaries                 0.0 0.0 0.0
Other non-operating—net                 3.9 1.9 54.5
Earnings before income taxes and equity in earnings of non-operating affiliates                 1,057.6 2,187.3 2,209.7
Income tax (benefit) provision                 395.8 773.0 686.5
Equity in (losses) earnings of non-operating affiliates—net of taxes                 72.3 22.5 9.6
Net earnings                 734.1 1,436.8 1,532.8
Less: Net earnings attributable to noncontrolling interest                 34.2 46.5 68.2
Net earnings attributable to common stockholders $ 26.5 $ 90.9 $ 351.9 $ 230.6 $ 238.3 $ 130.9 $ 312.6 $ 708.5 699.9 1,390.3 1,464.6
Reportable legal entities | Parent                      
Condensed, Consolidating Statement of Operations                      
Net sales                 0.0 0.0 0.0
Cost of sales                 0.0 0.0 0.0
Gross margin                 0.0 0.0 0.0
Selling, general and administrative expenses                 4.4 2.8 2.7
Transaction costs                 45.8    
Other operating—net                 0.0 0.0 0.0
Total other operating costs and expenses                 50.2 2.8 2.7
Gain on sale of phosphate business                   0.0  
Equity in earnings of operating affiliates                 0.0 0.0 0.0
Operating earnings                 (50.2) (2.8) (2.7)
Interest expense                 0.0 0.0 0.0
Interest income                 0.0 0.0 0.0
Net earnings of wholly-owned subsidiaries                 (731.2) (1,392.0) (1,466.4)
Other non-operating—net                 (0.1) (0.1) 0.0
Earnings before income taxes and equity in earnings of non-operating affiliates                 681.1 1,389.3 1,463.7
Income tax (benefit) provision                 (18.8) (1.0) (0.9)
Equity in (losses) earnings of non-operating affiliates—net of taxes                 0.0 0.0 0.0
Net earnings                 699.9 1,390.3 1,464.6
Less: Net earnings attributable to noncontrolling interest                 0.0 0.0 0.0
Net earnings attributable to common stockholders                 699.9 1,390.3 1,464.6
Reportable legal entities | CF Industries                      
Condensed, Consolidating Statement of Operations                      
Net sales                 462.2 712.2 1,105.8
Cost of sales                 361.6 528.6 886.0
Gross margin                 100.6 183.6 219.8
Selling, general and administrative expenses                 7.7 13.5 11.8
Transaction costs                 0.0    
Other operating—net                 (8.5) (5.0) 7.6
Total other operating costs and expenses                 (0.8) 8.5 19.4
Gain on sale of phosphate business                   764.5  
Equity in earnings of operating affiliates                 0.0 0.0 0.0
Operating earnings                 101.4 939.6 200.4
Interest expense                 285.1 246.9 155.1
Interest income                 (69.0) (0.2) (0.9)
Net earnings of wholly-owned subsidiaries                 (801.5) (969.2) (1,423.0)
Other non-operating—net                 0.0 0.0 (0.4)
Earnings before income taxes and equity in earnings of non-operating affiliates                 686.8 1,662.1 1,469.6
Income tax (benefit) provision                 (44.3) 270.0 3.0
Equity in (losses) earnings of non-operating affiliates—net of taxes                 0.0 (0.1) (0.2)
Net earnings                 731.1 1,392.0 1,466.4
Less: Net earnings attributable to noncontrolling interest                 0.0 0.0 0.0
Net earnings attributable to common stockholders                 731.1 1,392.0 1,466.4
Reportable legal entities | Other Subsidiaries                      
Condensed, Consolidating Statement of Operations                      
Net sales                 4,542.8 5,073.4 5,767.5
Cost of sales                 3,096.3 3,478.5 3,463.0
Gross margin                 1,446.5 1,594.9 2,304.5
Selling, general and administrative expenses                 157.7 135.6 151.5
Transaction costs                 11.1    
Other operating—net                 100.8 58.3 (23.4)
Total other operating costs and expenses                 269.6 193.9 128.1
Gain on sale of phosphate business                   (14.4)  
Equity in earnings of operating affiliates                 (35.0) 43.1 41.7
Operating earnings                 1,141.9 1,429.7 2,218.1
Interest expense                 (81.7) (68.5) (1.8)
Interest income                 (2.8) (0.9) (4.9)
Net earnings of wholly-owned subsidiaries                 0.0 0.0 0.0
Other non-operating—net                 4.0 2.0 54.9
Earnings before income taxes and equity in earnings of non-operating affiliates                 1,222.4 1,497.1 2,169.9
Income tax (benefit) provision                 458.9 504.0 684.4
Equity in (losses) earnings of non-operating affiliates—net of taxes                 72.3 22.6 9.8
Net earnings                 835.8 1,015.7 1,495.3
Less: Net earnings attributable to noncontrolling interest                 34.2 46.5 72.3
Net earnings attributable to common stockholders                 801.6 969.2 1,423.0
Eliminations                      
Condensed, Consolidating Statement of Operations                      
Net sales                 (696.7) (1,042.4) (1,398.6)
Cost of sales                 (696.7) (1,042.4) (1,394.5)
Gross margin                 0.0 0.0 (4.1)
Selling, general and administrative expenses                 0.0 0.0 0.0
Transaction costs                 0.0    
Other operating—net                 0.0 0.0 0.0
Total other operating costs and expenses                 0.0 0.0 0.0
Gain on sale of phosphate business                   0.0  
Equity in earnings of operating affiliates                 0.0 0.0 0.0
Operating earnings                 0.0 0.0 (4.1)
Interest expense                 (70.2) (0.2) (1.1)
Interest income                 70.2 0.2 1.1
Net earnings of wholly-owned subsidiaries                 1,532.7 2,361.2 2,889.4
Other non-operating—net                 0.0 0.0 0.0
Earnings before income taxes and equity in earnings of non-operating affiliates                 (1,532.7) (2,361.2) (2,893.5)
Income tax (benefit) provision                 0.0 0.0 0.0
Equity in (losses) earnings of non-operating affiliates—net of taxes                 0.0 0.0 0.0
Net earnings                 (1,532.7) (2,361.2) (2,893.5)
Less: Net earnings attributable to noncontrolling interest                 0.0 0.0 (4.1)
Net earnings attributable to common stockholders                 $ (1,532.7) $ (2,361.2) $ (2,889.4)